Abstract
Real-world effectiveness and safety of Janus kinase 1 inhibitors for the treatment of moderate-to-severe atopic dermatitis: a single-center, prospective study in China.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have